| Autor: |
Corrigan RR; 1Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA; email: Tracy.Bedrosian@NationwideChildrens.org., Mashburn-Warren LM; 1Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA; email: Tracy.Bedrosian@NationwideChildrens.org., Yoon H; 1Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA; email: Tracy.Bedrosian@NationwideChildrens.org., Bedrosian TA; 1Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA; email: Tracy.Bedrosian@NationwideChildrens.org.; 2Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA. |
| Abstrakt: |
Research efforts over the past decade have defined the genetic landscape of somatic variation in the brain. Neurons accumulate somatic mutations from development through aging with potentially profound functional consequences. Recent studies have revealed the contribution of somatic mosaicism to various brain disorders including focal epilepsy, neuropsychiatric disease, and neurodegeneration. One notable finding is that the effect of somatic mosaicism on clinical outcomes can vary depending on contextual factors, such as the developmental origin of a variant or the number and type of cells affected. In this review, we highlight current knowledge regarding the role of somatic mosaicism in brain disorders and how biological context can mediate phenotypes. First, we identify the origins of brain somatic variation throughout the lifespan of an individual. Second, we explore recent discoveries that suggest somatic mosaicism contributes to various brain disorders. Finally, we discuss neuropathological associations of brain mosaicism in different biological contexts and potential clinical utility. |
